Organization: Health Canada
Year: 2025
Month: February
Request Number: A-2024-000384
Request Summary: Adverse Drug Reaction (ADR) for Vedolizumab. Report number: 001083331. ADRs for Ondansetron. Report numbers: 001085629, E2B_07094075, 001086064. ADRs for Pantoloc. Report numbers: 001082313, E2B_07093184, 001085766. ADR for Pantoprazole sodium. Report number: E2B_07085288. ADRs for Tecta. Report numbers: E2B_07064750, 001084738.
Disposition: Disclosed in part
Number of pages: 2664